Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology

Giovanni Gambassi, Antonio Sgadari, Roberto Bernabei, Pierugo Carbonin, Kl Lapane, C Gatsonis, La Lipsitz, V Mor

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.
Lingua originaleEnglish
pagine (da-a)53-60
Numero di pagine8
RivistaArchives of Internal Medicine
Volume160
Stato di pubblicazionePubblicato - 2000

Keywords

  • Activities of Daily Living
  • Aged
  • Aged, 80 and over
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Confounding Factors (Epidemiology)
  • Digoxin
  • Drug Therapy, Combination
  • Female
  • Heart Failure
  • Hospitalization
  • Humans
  • Male
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology'. Insieme formano una fingerprint unica.

Cita questo